The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 37306641.
- Also identified by DOI 10.1016/j.jtcvs.2023.04.039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.
Medical subject headings
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Thoracic Surgery
- Small Cell Lung Carcinoma